FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease

By Jen Christensen, CNN The US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease. Donanemab, made by Indianapolis-based Eli Lilly, works by helping the body remove amyloid plaque buildup in the brain, a hallmark of Alzheimer’s disease.
Neurovations Receives 2022 Best of Napa Award for Outstanding COVID Testing Services

NapaCovid has been selected for the 2022 Best of Napa Award in the Medical Clinic category.
Napa County Partnership Brings Testing to the Vineyard

Local Healthcare Entrepreneur, Winery, Napa Valley Vintners and Advocates Join Forces to Bring Testing to Farmworkers NAPA, Calif., August 11, 2020 (Newswire.com) – Community leader Lydia Mondavi, local physician and founder of Neurovations, Dr. Eric Grigsby, and the Napa Valley Vintners have collectively formed a partnership to bring COVID-19 testing to wineries, essential workers, farmworkers and hospitality workers throughout the Napa Valley. […]
Web Content Accessibility

The Neurovations family of businesses is committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone and applying the relevant accessibility standards. We are taking strong measures to ensure accessibility to all of our websites, pages, and forms. Our goal is to meet or exceed Web Content […]
Dr. Eric Grigsby Recognized for Visionary Leadership in Pain Management

CEO and Founder of Neurovations Honored as Patient Champion NAPA, Calif., October 16, 2019 (Newswire.com) – Dr. Eric Grigsby was awarded the Visionary Leadership Award at the 6th Annual Business of Pain Medicine Conference in Washington D.C. last week. Dr. Grigsby was honored for recognizing pain as a valid disease and acting as a patient champion, […]